Core Insights - The company reported a revenue of 47.35 million yuan for the first half of 2025, representing a year-on-year decline of 17.15% [1] - The net profit attributable to shareholders was -14.82 million yuan, a decrease of 32.22% compared to the previous year [1] Financial Performance - Revenue for the first half of 2025: 47.35 million yuan, down 17.15% year-on-year [1] - Net profit attributable to shareholders: -14.82 million yuan, down 32.22% year-on-year [1] - Foreign revenue reached 9.44 million yuan, an increase of 7.60% year-on-year, driven by the recovery of import repair business and the export of gradient coils [1] Cost Management - Sales expenses decreased by 22.63% compared to the same period last year [1] - Management expenses reduced by 20.80% year-on-year [1] Research and Development - R&D expenses amounted to 16.50 million yuan, an increase of 34.79% year-on-year, accounting for 34.84% of total revenue [1] - Focus areas include MRI system integration technology, 7.0T and multi-core high-end RF detectors, and superconducting magnets [1] - Some R&D outcomes have already been applied to the company's products [1] Product Development - The company is expanding its medical imaging equipment product line and advancing new product registration and commercialization [1] - The digital X-ray machine (DR) has obtained medical device registration and is in the market promotion phase [1] - The CT project has completed prototype production and is in the new product registration review stage [1][2]